News Detail
Mumbai, 31 March 2025: Dabur India Ltd has told the Bombay High Court that it will withdraw terms like "anti-inflammatory," "anti-bacterial," and "analgesic" from the labels of its two toothpaste products with effect from June 2025.
The move follows co......
View Details
Source : Free Press Journal
Dabur toothpaste label change
FDA concerns on Dabur toothpaste
Dabur Meswak toothpaste claims
Dabur Herb1 Anti-Bacterial Toothpaste
Bombay High Court on Dabur
Toothpaste labelling compliance
Anti-inflammatory claim removal
Anti-bacterial claim dispute
Analgesic claim on toothpaste
Maharashtra FDA order on Dabur
Related News
- WHO issues its first-ever reports on tests and treatments for invasive fungal diseases (01-04-2025)
- 3 companies fail to prove 'skin whitening' claims, fined (01-04-2025)
- 26,326 misleading advertisements related to Ayush medicines noticed from March 2022 to February 2025: Govt in RS (01-04-2025)
- SUGAM labs in place since Sept, 2023 for integrating CDSCO drug testing labs: Govt in RS (01-04-2025)
- Maharashtra starts inspection of blood banks to check violation (01-04-2025)
- 18 states and 5 UTs did not submit NSQ data with Centre in February (01-04-2025)
- Prolonged use of antidepressants linked to risk of sudden cardiac death: Study (01-04-2025)
- Drug Smuggler on the Run arrested in Jodhpur (01-04-2025)
- New digital portal to track rabies vaccine, anti-snake venom stocks (01-04-2025)
- iOS 19.4 to offer revamped Health app with virtual doctor feature: Report (01-04-2025)